Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1977 2
1978 1
2000 1
2002 1
2005 3
2006 1
2008 3
2009 5
2011 2
2012 1
2013 2
2014 1
2015 4
2016 3
2020 1
2021 2
2022 1
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Intensive versus conventional glucose control in critically ill patients.
NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. NICE-SUGAR Study Investigators, et al. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24. N Engl J Med. 2009. PMID: 19318384 Free article. Clinical Trial.
Intensity of continuous renal-replacement therapy in critically ill patients.
RENAL Replacement Therapy Study Investigators; Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. RENAL Replacement Therapy Study Investigators, et al. N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413. N Engl J Med. 2009. PMID: 19846848 Free article. Clinical Trial.
Academia Meets Industry.
Schäfer C, Paprotka T, Heitzer E, Eccleston M, Noe J, Holdenrieder S, Diehl F, Thierry A. Schäfer C, et al. Among authors: eccleston m. Adv Exp Med Biol. 2016;924:201-215. doi: 10.1007/978-3-319-42044-8_36. Adv Exp Med Biol. 2016. PMID: 27753044
Precision epigenetic therapies in oncology.
Chaudhary A, Orchard KJA, Salani F, Partsou T, Eccleston M, Bocci G, Italiano A, Crea F. Chaudhary A, et al. Among authors: eccleston m. Cancer Metastasis Rev. 2025 Sep 19;44(4):71. doi: 10.1007/s10555-025-10288-w. Cancer Metastasis Rev. 2025. PMID: 40968252 Free PMC article. Review.
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines.
Latarani M, Pucci P, Eccleston M, Manzo M, Gangadharannambiar P, Fischetti I, Alborelli I, Mongiardini V, Mahmood N, Colombo MP, Grimaldi B, Rigas S, Akamatsu S, Hawkes C, Wang Y, Jachetti E, Crea F. Latarani M, et al. Among authors: eccleston m. Epigenomics. 2025 Feb;17(3):145-154. doi: 10.1080/17501911.2025.2453419. Epub 2025 Jan 29. Epigenomics. 2025. PMID: 39878501 Free PMC article.
ValiRx plc.
Eccleston M, Morris G. Eccleston M, et al. Per Med. 2008 Sep;5(5):441-445. doi: 10.2217/17410541.5.5.441. Per Med. 2008. PMID: 29783450
Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose.
Bellomo R, Mårtensson J, Lo S, Kaukonen KM, Cass A, Gallagher M; RENAL study investigators; Australian and New Zealand Intensive Care Clinical Trials Group. Bellomo R, et al. Blood Purif. 2016;41(1-3):11-7. doi: 10.1159/000439581. Epub 2015 Oct 20. Blood Purif. 2016. PMID: 26485539 Free article. Clinical Trial.
39 results